2020 Keynote Speakers


8:00 am Registration and Morning Coffee


8:35 Welcome by Conference Organizer

Micah Lieberman, Executive Director, Conferences, Cambridge Healthtech Institute (CHI)

8:40 Chairperson's Remarks

Oriol Serra OrtizOriol Serra Ortiz, Head of Site Intelligence & Site Selection, Study Optimization Global Product Development, Pfizer Inc.





8:45 CO-PRESENTATION: Moving the Needle in a Large Clinical Trial Portfolio through Innovation and Communication: Sanofi's Patient and Investigator Site-Focused Programs

Vicky DiBiasoVicky DiBiaso, MPH, BScN, Regional Head, Asia Pacific, Eurasia, Middle East & Africa, Sanofi






Megan HeathMegan Heath, Vice President, Region Head, Clinical Studies Unit Europe, Sanofi





Thanks to a global effort focusing on reducing site burden, Sanofi rose to the #1 position in the CenterWatch Survey in 2019.This was the biggest jump any sponsor had achieved in consecutive surveys. In parallel, Sanofi has continued their patient-informed R&D model, bringing the patient voice into each of their programs. This has been the catalyst for various award-winning recognitions and further supported accelerated medicines development.

9:10 Empowering Patients through a Fully Digitalized Experience

Mohanad ForsMohanad Fors, Head, Global Commercial Digital Innovation, Almirall LLC

Patients are the center of all our actions and our daily work. Digital solutions are providing unique channels and opportunities when it comes to our patients' interactions. We are experiencing new dimensions in this world of direct-to-patient trials, remote trials, virtual trials, and seamless digital interactions. A special set of technical capabilities and a relationship with patients based on trust is required to lead us through a fully digitalized experience through the whole treatment journey. What is the role of patients in the new treatment regimens and how has this changed in the digital era? What are the key challenges? Digital solutions vary from simple patient support programs to digital therapeutics and complete virtual interactions. In the session, we will be covering the new patient journey now and in the future with new understanding of the patient's role in the management of digital assets and digital panning.

9:35 CASE STUDY CO-PRESENTATION: Connecting Patients…From Successful Pilot to Implementation

Caroline FeysCaroline Feys, MSc, MBA, Leader, R&D Operations Innovation, Janssen Pharmaceutica NV






Annick BessemsAnnick Bessems, Director & Clinical Program Leader, Oncology, Janssen Pharmaceutica NV





Patients make clinical trials possible and their needs must be at the center of everything that we do. Did you know that only about 25% of patients worldwide are aware of clinical trials? And 90% of those patients who participated in clinical trials never receive their data or results from that trial? My Trial Community is an information hub for patients connecting them and other members of the clinical trial community before, during, and after a clinical trial. Direct-to-Participant supports the evolving need to conduct elements of a clinical trial outside of the clinical trial site. This talk will share how Janssen used Patient Voice to inform My Trial Community and Direct-to-Participant capabilities, how we scaled up to minimize barriers and achieve success factors, and the value of Data Return in building and sustaining positive engagements with our volunteers.

10:00 Grand Opening Coffee Break in the Exhibit Hall

thursday 15 OCTOBER


2:35 Chairperson's Remarks

2:40 Clinical Research News European Innovations Awards

Benjamin RossBenjamin Ross, Senior Editorial Assistant, Clinical Research News, Bio-IT World & Diagnostics World

Clinical Research News is seeking submissions to its European Innovations Awards. This awards program recognizes outstanding examples of applied strategic innovation—partnerships, deployments, and collaborations that manifestly improve the clinical trial process. Judges are looking for thoughtful approaches to tough industry problems, approaches that have been used and proven, quantify ROI, and explain how the solution could be deployed by others. Project results are more important than product feature lists.

Entry Criteria: The work for which recognition is sought must have been done in the last two years and be substantially complete. Nominations are open to R&D and scientific facilities and labs in pharmaceutical companies, biotech companies, academia, government, medical, or related institutions and organizations, as well as public and private research organizations.

We encourage all SCOPE Europe Exhibitors and Sponsors to participate!
Send direct questions about entry criteria/process and email completed entry to:
Benjamin Ross, Senior Editorial Assistant, 781.247.1818 or bross@healthtech.com
Subject: 2020 European Innovations Awards
Final Deadline: July 10, 2020

2:45 Design as the Ultimate Expression of Strategy: How to Empower the Execution of Bold Ideas

Majid IqbalMajid Iqbal, Special Advisor, Strategy and Design, Ministerie van Defensie; Author, Thinking in Services

Strategic design is the process of translating game-changing decisions into clear, concise, and complete instructions for execution: the who, why, how, what, when, and where of operations. Encoding them into the designs of systems and services allows us to “take more risk while avoiding it.” Having it both ways requires dexterity in switching between the abstract and the concrete. It requires thinking and tooling that is at once simple and sophisticated, advanced and primitive. This talk gives two examples of strategic design in practice: within a government agency and a major healthcare initiative.

3:10 Evolving from the Pandemic: Moving toward a New Vision for Clinical Trials in 2030

Pamela TenaertsPamela Tenaerts, MD, MBA, Executive Director, Clinical Trials Transformation Initiative (CTTI)






Pierre MeulienPierre Meulien, PhD, Executive Director, Innovative Medicines Initiative (IMI)






In the face of the COVID-19 pandemic, the clinical trials ecosystem has moved rapidly to implement a range of innovative approaches – from running virtual visits and using mobile technologies, to streamlining trial designs and running master protocols – in an effort to quickly evaluate promising therapeutics without rebuilding research infrastructure. In this keynote presentation, the executive directors of the Clinical Trials Transformation Initiative (CTTI) and the Innovative Medicines Initiative (IMI) will discuss:

  • How the COVID-19 pandemic is transforming the clinical trials ecosystem
  • Emerging best practices for planning and conducting high-quality clinical trials in the current global landscape
  • A multi-stakeholder vision for sustaining and driving innovation in clinical trial design and execution into the next decade

3:35 Extended Q&A and Closing Panel with CTTI and IMI

3:50 Organizer's Closing Remarks

4:00 Close of Summit